NO963029L - Anvendelse av IL-10 for å stimulere cytologisk aktivitet av enkjernete celler i perifert blod - Google Patents

Anvendelse av IL-10 for å stimulere cytologisk aktivitet av enkjernete celler i perifert blod

Info

Publication number
NO963029L
NO963029L NO963029A NO963029A NO963029L NO 963029 L NO963029 L NO 963029L NO 963029 A NO963029 A NO 963029A NO 963029 A NO963029 A NO 963029A NO 963029 L NO963029 L NO 963029L
Authority
NO
Norway
Prior art keywords
peripheral blood
stimulate
blood cells
core peripheral
cytological activity
Prior art date
Application number
NO963029A
Other languages
English (en)
Norwegian (no)
Other versions
NO963029D0 (no
Inventor
Martin A Schwarz
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO963029D0 publication Critical patent/NO963029D0/no
Publication of NO963029L publication Critical patent/NO963029L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the cancer treated
    • A61K2239/48—Blood cells, e.g. leukemia or lymphoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
NO963029A 1994-01-20 1996-07-19 Anvendelse av IL-10 for å stimulere cytologisk aktivitet av enkjernete celler i perifert blod NO963029L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IB1994/000008 WO1995019780A1 (en) 1994-01-20 1994-01-20 Use of il-10 to stimulate peripheral blood mononuclear cell cytolytic activity
CN94194863A CN1142186A (zh) 1994-01-20 1994-01-20 用白介素-10激活外周血单核细胞的细胞溶解活性

Publications (2)

Publication Number Publication Date
NO963029D0 NO963029D0 (no) 1996-07-19
NO963029L true NO963029L (no) 1996-09-19

Family

ID=37708148

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963029A NO963029L (no) 1994-01-20 1996-07-19 Anvendelse av IL-10 for å stimulere cytologisk aktivitet av enkjernete celler i perifert blod

Country Status (10)

Country Link
EP (1) EP0740552A1 (pl)
JP (1) JPH09508116A (pl)
CN (1) CN1142186A (pl)
AU (1) AU707019B2 (pl)
FI (1) FI962813A7 (pl)
NO (1) NO963029L (pl)
NZ (1) NZ259584A (pl)
PL (1) PL175343B1 (pl)
SK (1) SK91696A3 (pl)
WO (1) WO1995019780A1 (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000037096A2 (en) * 1998-12-22 2000-06-29 Schering Corporation Treatment of hepatitis c virus infections with interleukin-10
ES2367891T3 (es) 2000-09-29 2011-11-10 Schering Corporation Interleucina-10 pegilada.
RU2322452C2 (ru) * 2006-03-27 2008-04-20 Михаил Николаевич Смирнов Иммуномодулирующая композиция
MX2009003362A (es) * 2006-09-28 2009-06-08 Schering Corp Uso de interleucina-10 pegilada para tratamiento de cancer.
WO2009003185A1 (en) * 2007-06-27 2008-12-31 Joslin Diabetes Center, Inc. Regulatory t cells in adipose tissue
PT2379115T (pt) 2008-12-17 2018-01-03 Merck Sharp & Dohme Produção de mono- e di-peg-il-10; e utilizações
EP2986306A4 (en) 2013-04-18 2016-12-07 Armo Biosciences Inc METHOD FOR USE OF INTERLEUKIN-10 FOR THE TREATMENT OF ILLNESSES AND SUFFERING
AU2014281828B2 (en) 2013-06-17 2019-05-09 Armo Biosciences, Inc. Method for assessing protein identity and stability
HK1226308A1 (zh) 2013-08-30 2017-09-29 Armo Biosciences, Inc. 使用白细胞介素-10治疗疾病和病症的方法
BR112016010166A2 (pt) 2013-11-11 2017-12-05 Armo Biosciences Inc métodos para usar interleucina-10 para tratar doenças e distúrbios
CN106573072A (zh) 2014-06-02 2017-04-19 阿尔莫生物科技股份有限公司 降低血清胆固醇的方法
JP2017536098A (ja) 2014-10-14 2017-12-07 アルモ・バイオサイエンシーズ・インコーポレイテッド インターロイキン−１５組成物及びその使用
EP3209320B1 (en) 2014-10-22 2023-03-08 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
WO2016126615A1 (en) 2015-02-03 2016-08-11 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
CN107847583A (zh) 2015-05-28 2018-03-27 阿尔莫生物科技股份有限公司 用于治疗癌症的聚乙二醇化白细胞介素‑10
JP7053453B2 (ja) 2015-08-25 2022-04-12 アルモ・バイオサイエンシーズ・インコーポレイテッド 疾患及び障害を治療するためのインターロイキン１０の使用方法
AU2022374787A1 (en) * 2021-10-25 2024-05-02 Ellennbe Gmbh Pharmaceutical composition and kit comprising an immunomodulatory substance for treating diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0567586T3 (da) * 1991-01-16 1995-12-04 Schering Corp Anvendelse af interleukin-10 ved adoptiv immunterapi af cancer
FI933193L (fi) * 1991-01-16 1993-07-14 Schering Corp Behandling av neoplastisk sjukdom med interleukin-10
US5055045A (en) * 1991-03-18 1991-10-08 Dickie Robert G Disposable dental matrix retainer clamp

Also Published As

Publication number Publication date
PL175343B1 (pl) 1998-12-31
FI962813A0 (fi) 1996-07-11
AU707019B2 (en) 1999-07-01
WO1995019780A1 (en) 1995-07-27
EP0740552A1 (en) 1996-11-06
FI962813L (fi) 1996-07-11
JPH09508116A (ja) 1997-08-19
FI962813A7 (fi) 1996-07-11
NZ259584A (en) 1998-01-26
CN1142186A (zh) 1997-02-05
NO963029D0 (no) 1996-07-19
AU5842594A (en) 1995-08-08
SK91696A3 (en) 1997-04-09
PL315513A1 (en) 1996-11-12

Similar Documents

Publication Publication Date Title
NO963029L (no) Anvendelse av IL-10 for å stimulere cytologisk aktivitet av enkjernete celler i perifert blod
EA200600076A1 (ru) Композиции и способы увеличения активности теломеразы
DK545584D0 (da) Enzym-resistente immonumodulatoriske peptider
ATE153856T1 (de) Zusammensetzung zur stimulierung des immunsystems
NO990916L (no) Bruk av GLP-1 eller analoger i behandlingen av myokardialt infarkt
BR0212252A (pt) Métodos para reduzir a hipertensão e a insuficiência cardìaca em um mamìfero
KR950700333A (ko) 개량된 알파 인터페론 조성물 및 인간 말초혈 백혈구로부터의 제조 방법(improved alpha interferon composition and method for its production from human peripheral blood leukocytes)
MX169205B (es) Composicion para estimular el crecimiento del cabello
FR2777183B1 (fr) Utilisation d'au moins un hydroxystilbene dans une composition destinee a favoriser la desquamation de la peau et composition le comprenant
NZ332720A (en) Therapeutic uses of bactericidal/permeability increasing (BPI) protein to treat human meningococcemia
EP0211354A3 (en) Nucleosides and their use as antineoplastic agents
GR1002802B (el) Καλλυντικες συνθεσεις και συνθεσεις περιποιησεως του δερματος
GB2187955B (en) Improvements in or relating to the treatment of sickle cell disease
DE69725882D1 (de) Adenovirus e4 proteine für induktion von zelltod
WO2000004863A3 (en) Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
ATE81467T1 (de) Immunosuppression bei der auf immunotoxin basierten behandlung von menschen.
MXPA00010254A (es) Tratamiento de disfuncion sexual en ciertos grupos de pacientes.
ES8704962A1 (es) Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida.
HU9201197D0 (en) Protection from shock subsequent to injury by double-stranded rns
MY131599A (en) Use of il-10 to stimulate peripheral blood mononuclear cell cytolytic activity
DE3373978D1 (en) Composition for the care or treatment of the human skin
PT1032402E (pt) Uso de citicolina para o tratamento de esclerose multipla
EP0668771A4 (en) TREATMENT OF AUTOIMMUNE DISEASES BY TOLERANCE IN CELLS, TISSUES AND ORGANS.
ZA873928B (en) Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease
JPS6485990A (en) Antihypertestoeronemia agent